전체 8345
-
- NIH State-of-the-Science Conference: Family History and Improving Health - Day 1
-
- - NIH State-of-the-Science Conference
National Human Genome Research Institute (U.S.) (2010/11/18) - - Category : Conferences
- - NIH State-of-the-Science Conference
- Many common diseases have genetic, environmental, and lifestyle causes that family members may share. An individual？？？s family health history captures information about shared factors that contribute to that individual？？？s risk for developing diseases such as diabetes, stroke, cancer, and heart disease. Family health history information collected from patients has long been used as a risk assessment tool by health care providers in the United States. Family history is also critical to determining who will benefit from genetic testing for both common and rare conditions, and can facilitate interpretation of genetic test results. The combination of these attributes makes the collection of family history an important first step in personalized medicine.
Recently there have been a number of national efforts to ensure that family history information is effectively incorporated into health information technology systems including electronic health records and personal health record systems. An ultimate goal of these efforts will be to provide clinicians with automated clinical decision tools based on family history information; this will require a sound scientific foundation on which to develop such tools.
Although most individuals are accustomed to providing some form of family history information when they visit health professionals, there is wide variation in the way family history is collected and used by health care providers. Moreover, the accuracy of a patient-gathered history may be limited by an individual？？？s awareness, understanding, and recollection of their family members？？？ health issues. Important questions remain regarding the effectiveness of family history information for disease prediction and improvement of patient health outcomes.
There may also be adverse effects for both individuals and society, thus far not fully understood, of depending too heavily on a family history to assess disease risk. It is possible that emphasizing family history may have economic costs as well, as limited resources are allocated across a wide variety of health promotion activities in the primary care setting.
In order to take a closer look at this important topic, the National Human Genome Research Institute and the Office of Medical Applications of Research of the National Institutes of Health will convene a State-of-the-Science conference from August 24 to 26, 2009, to assess the available scientific evidence related to the following questions:- What are the key elements of a family history in a primary care setting for the purposes of risk assessment for common diseases?
- What is the accuracy of the family history, and under what conditions does the accuracy vary?
- What is the direct evidence that getting a family history will improve health outcomes for the patient and/or family?
- What is the direct evidence that getting a family history will result in adverse outcomes for the patient and/or family?
- What are the factors that encourage or discourage obtaining and using a family history?
- What are future research directions for assessing the value of family history for common diseases in the primary care setting?
VideoCast viewers will be able to submit comments on the conference panels draft statement Wednesday morning, between 8:30 and 11:30 am. Visit
http://www.meetinglink.org/omar-statements/FHIH/PublicComments.aspx
NIH State-of-the-Science Conference: Family History and Improving Health - Day 1
-
- NIH State-of-the-Science Conference: Family History and Improving Health - Day 2
-
- - Sponsored by NHGRI (2010/11/18)
- - Category : Conferences
- Many common diseases have genetic, environmental, and lifestyle causes that family members may share. An individual？？？s family health history captures information about shared factors that contribute to that individual？？？s risk for developing diseases such as diabetes, stroke, cancer, and heart disease. Family health history information collected from patients has long been used as a risk assessment tool by health care providers in the United States. Family history is also critical to determining who will benefit from genetic testing for both common and rare conditions, and can facilitate interpretation of genetic test results. The combination of these attributes makes the collection of family history an important first step in personalized medicine.
Recently there have been a number of national efforts to ensure that family history information is effectively incorporated into health information technology systems including electronic health records and personal health record systems. An ultimate goal of these efforts will be to provide clinicians with automated clinical decision tools based on family history information; this will require a sound scientific foundation on which to develop such tools.
Although most individuals are accustomed to providing some form of family history information when they visit health professionals, there is wide variation in the way family history is collected and used by health care providers. Moreover, the accuracy of a patient-gathered history may be limited by an individual？？？s awareness, understanding, and recollection of their family members？？？ health issues. Important questions remain regarding the effectiveness of family history information for disease prediction and improvement of patient health outcomes.
There may also be adverse effects for both individuals and society, thus far not fully understood, of depending too heavily on a family history to assess disease risk. It is possible that emphasizing family history may have economic costs as well, as limited resources are allocated across a wide variety of health promotion activities in the primary care setting.
In order to take a closer look at this important topic, the National Human Genome Research Institute and the Office of Medical Applications of Research of the National Institutes of Health will convene a State-of-the-Science conference from August 24 to 26, 2009, to assess the available scientific evidence related to the following questions:- What are the key elements of a family history in a primary care setting for the purposes of risk assessment for common diseases?
- What is the accuracy of the family history, and under what conditions does the accuracy vary?
- What is the direct evidence that getting a family history will improve health outcomes for the patient and/or family?
- What is the direct evidence that getting a family history will result in adverse outcomes for the patient and/or family?
- What are the factors that encourage or discourage obtaining and using a family history?
- What are future research directions for assessing the value of family history for common diseases in the primary care setting?
VideoCast viewers will be able to submit comments on the conference panels draft statement Wednesday morning, between 8:30 and 11:30 am. Visit
http://www.meetinglink.org/omar-statements/FHIH/PublicComments.aspx
NIH State-of-the-Science Conference: Family History and Improving Health - Day 2
-
- Clinical Fellows Rounds: Knowledge Translation Research Type 2: Where the Smart Researchers Are Going
-
- - Haynes, R Brian.
National Institutes of Health (U.S.) (2010/11/18) - - Category : Clinical Center Grand Rounds
- - Haynes, R Brian.
- Clinical Center Grand Rounds
R. Brian Haynes, MD, PhD
Professor of Clinical Epidemiology and Biostatistics
Chief, Health Information Research Unit, Faculty of Health Sciences
McMaster University
For more information, visit
http://www.cc.nih.gov/about/news/grcurrent.html
Clinical Fellows Rounds: Knowledge Translation Research Type 2: Where the Smart Researchers Are Going
-
- NIH State-of-the-Science Conference: Family History and Improving Health - Day 3
-
- - Sponsored by NHGRI (2010/11/18)
- - Category : Conferences
- Many common diseases have genetic, environmental, and lifestyle causes that family members may share. An individual？？？s family health history captures information about shared factors that contribute to that individual？？？s risk for developing diseases such as diabetes, stroke, cancer, and heart disease. Family health history information collected from patients has long been used as a risk assessment tool by health care providers in the United States. Family history is also critical to determining who will benefit from genetic testing for both common and rare conditions, and can facilitate interpretation of genetic test results. The combination of these attributes makes the collection of family history an important first step in personalized medicine.
Recently there have been a number of national efforts to ensure that family history information is effectively incorporated into health information technology systems including electronic health records and personal health record systems. An ultimate goal of these efforts will be to provide clinicians with automated clinical decision tools based on family history information; this will require a sound scientific foundation on which to develop such tools.
Although most individuals are accustomed to providing some form of family history information when they visit health professionals, there is wide variation in the way family history is collected and used by health care providers. Moreover, the accuracy of a patient-gathered history may be limited by an individual？？？s awareness, understanding, and recollection of their family members？？？ health issues. Important questions remain regarding the effectiveness of family history information for disease prediction and improvement of patient health outcomes.
There may also be adverse effects for both individuals and society, thus far not fully understood, of depending too heavily on a family history to assess disease risk. It is possible that emphasizing family history may have economic costs as well, as limited resources are allocated across a wide variety of health promotion activities in the primary care setting.
In order to take a closer look at this important topic, the National Human Genome Research Institute and the Office of Medical Applications of Research of the National Institutes of Health will convene a State-of-the-Science conference from August 24 to 26, 2009, to assess the available scientific evidence related to the following questions:- What are the key elements of a family history in a primary care setting for the purposes of risk assessment for common diseases?
- What is the accuracy of the family history, and under what conditions does the accuracy vary?
- What is the direct evidence that getting a family history will improve health outcomes for the patient and/or family?
- What is the direct evidence that getting a family history will result in adverse outcomes for the patient and/or family?
- What are the factors that encourage or discourage obtaining and using a family history?
- What are future research directions for assessing the value of family history for common diseases in the primary care setting?
VideoCast viewers will be able to submit comments on the conference panels draft statement Wednesday morning, between 8:30 and 11:30 am. Visit
http://www.meetinglink.org/omar-statements/FHIH/PublicComments.aspx
NIH State-of-the-Science Conference: Family History and Improving Health - Day 3
-
- GovTrip HPOC Kick-Off Meeting (NIH-Only)
-
- - Jennifer Martin, NBS GovTrip Project Lead (2010/11/18)
- - Category : Travel (NIH Only)
- The GovTrip HPOC Kick-Off Meeting will present the current status of the GovTrip deployment and address HPOC specific training opportunities. HPOCs will view a demo of the GovTrip system and receive additional information on system access and other helpful tools for assisting users during the GovTrip deployment in their IC.
GovTrip HPOC Kick-Off Meeting (NIH-Only)
-
- Intramural/Extramural AO Meeting - GovTrip (NIH-Only)
-
- - Jennifer Martin, NBS GovTrip Project Lead (2010/11/18)
- - Category : Travel (NIH Only)
- The Intramural/Extramural AO Meeting will present information on the GovTrip deployment timeline and training strategy for the IC rollout as well as pre and post deployment support plans. Additionally, the NBS team will share steps that can taken to ready ICs for the GovTrip implement; FAQs and common issues with the GovTrip system will be discussed and there will be a demo of the five best features of the new system.
Intramural/Extramural AO Meeting - GovTrip (NIH-Only)
-
- PSI: Biology VideoCast Briefing
-
- - Jeremy Berg, Catherine Lewis and Peter Preusch (2010/11/18)
- - Category : Special
- Drs. Berg (Director, NIGMS), Lewis (Director, Div Cell Biology and Biophysics, NIGMS), and Preusch (Program Director for the PSI:Biology Program) will discuss the recently released RFAs that will establish the PSI:Biology Network. They will take Q&A from viewers via telephone and email. The PSI:Biology program is a new direction for the NIGMS supported Protein Structure Initiative that will establish a series of Centers for High-Throughput Structure Determination, Centers for Membrane Protein Structure Determination, and Centers for High-Throughput Enabled Structural Biology Partnerships.
For more information, visit
http://www.nigms.nih.gov/Initiatives/PSI/psi_biology
PSI: Biology VideoCast Briefing
-
- NIH Grantsmanship Workshop for Researchers with the Trans-Caribbean HIV/AIDS Research Alliance
-
- - Sponsored by the Office Of AIDS Research (2010/11/18)
- - Category : Special
- 내용 없음
NIH Grantsmanship Workshop for Researchers with the Trans-Caribbean HIV/AIDS Research Alliance
-
- Integrated Structural Biology of Gene Transcription
-
- - Cramer, Patrick.
National Institutes of Health (U.S.). Structural Biology Interest Group. (2010/11/18) - - Category : Structural Biology
- - Cramer, Patrick.
- The SBIG is a clearinghouse for discussions and interactions between scientists interested in all aspects of molecular structure, from experimental determination by x-ray crystallography, electron microscopy, mass spectrometry, and NMR, to theoretical and computational biology and biophysics, and to the biological application of structural data.
For more information, visit
Structural Biology Interest Group
Integrated Structural Biology of Gene Transcription
-
- Using Technology and Behavior to Direct Treatment Development Strategies
-
- - Lukas, Scott E.
National Institute of Mental Health (U.S.). Division of Adult Translational Research and Treatment Development. (2010/11/18) - - Category : Special
- - Lukas, Scott E.
- NIMH DATR Director Candidate Lecture
Scott E. Lukas, Ph.D.
Interim Director, NeuroImaging Center, McLean Hospital, Belmont, MA
Using Technology and Behavior to Direct Treatment Development Strategies
-
- CVs and Resumes: Essential Job Search Documents
-
- - Sponsored by the NIH Office of Intramural Training & Education (2010/11/18)
- - Category : Career Development/OITE
- Objective: This workshop will highlight the critical elements and structure of both CVs and resumes. These important job documents serve as the foundation for all job searches, and knowing how to create them based on the employment sector and published position description is essential.
Speaker:
Lori Conlan, PhD, Director of Postdoctoral Services
CVs and Resumes: Essential Job Search Documents
-
- CC Grand Rounds: (1) Update on Mood Disorders: International Patterns and Impact of Mood Disorders (2) An Update on Drug Discovery and Treatment Biomarker Development in Mood Disorders at NIMH
-
- - Zarate, Carlos A.
National Institutes of Health (U.S.) (2010/11/18) - - Category : Clinical Center Grand Rounds
- - Zarate, Carlos A.
- Clinical Center Grand Rounds
Kathleen R. Merikangas, PhD
Chief, Genetic Epidemiology Research Branch, NIMH
Carlos A. Zarate, Jr, MD
Chief, Mood Disorders Research Unit, Mood and Anxiety Disorders Program, NIMH
For more information, visit
http://www.cc.nih.gov/about/news/grcurrent.html
CC Grand Rounds: (1) Update on Mood Disorders: International Patterns and Impact of Mood Disorders (2) An Update on Drug Discovery and Treatment Biomarker Development in Mood Disorders at NIMH
-
- Cancer and Stem Cell Interplay in the Bone Marrow Niche
-
- - Sipkins, Dorothy.
National Institutes of Health (U.S.). Stem Cell Interest Group. (2010/11/18) - - Category : Stem Cell
- - Sipkins, Dorothy.
- The Stem Cell Interest Group was established to enhance communication and to foster collaboration among scientists from varying disciplines interested in stem cells. Topics of interest include fundamental stem cell biology, ontogeny, gerontology, and the therapeutic potential of stem cells. The SCIG serves as an open forum for discussion and dissemination of knowledge about all aspects of stem cell biology
For more information, visit
http://sigs.nih.gov/scig/Pages/default.aspx
Cancer and Stem Cell Interplay in the Bone Marrow Niche
-
- Alpha4Beta7: A Newly Recognized Receptor for HIV and its Role in HIV Pathogenesis
-
- - Fauci, Anthony S.
National Institutes of Health (U.S.). Immunology Interest Group. (2010/11/18) - - Category : Immunology
- - Fauci, Anthony S.
Alpha4Beta7: A Newly Recognized Receptor for HIV and its Role in HIV Pathogenesis
-
- Great Teachers: Treatment of Early Breast Cancer
-
- - Wolmark, Norman.
National Institutes of Health (U.S.) (2010/11/18) - - Category : Clinical Center Grand Rounds
- - Wolmark, Norman.
- Contemporary Clinical Medicine: Great Teachers
Norman Wolmark, MD
Chairman, National Surgical Adjuvant Breast and Bowel Project Professor and Chairman, Department of Human Oncology, Drexel University College of Medicine
Chairman, Department of Human Oncology, Allegheny General Hospital
For more information, visit
http://www.cc.nih.gov/about/news/grcurrent.html
Great Teachers: Treatment of Early Breast Cancer
-
- Constituents Meeting with NIH Director Dr. Francis Collins
-
- - Collins, Francis S.
National Institutes of Health (U.S.) (2010/11/18) - - Category : Special
- - Collins, Francis S.
- 내용 없음
Constituents Meeting with NIH Director Dr. Francis Collins
-
- Evaluation of Resveratrol and Curcumin as Therapeutics Against High Risk Leukemia
-
- - Zunino, Susan.
National Cancer Institute (U.S.). Office of Cancer Complementary and Alternative Medicine. (2010/11/18) - - Category : OCCAM Monthly Lecture Series
- - Zunino, Susan.
- The NCIs Office of Cancer Complementary and Alternative Medicine (OCCAM) invites you to view its monthly lecture series.
With the goal of informing the National Cancer Institute (NCI) community about the variety of ongoing research in cancer and complementary and alternative medicine (CAM), NCIs Office of Cancer Complementary and Alternative Medicine (OCCAM) has created a monthly lecture series on cancer CAM. These hour long lectures, occurring from 10 a.m. - 11 a.m. on the second Wednesday of each month, will feature a fifty minute presentation on a cancer CAM topic and allow ten minutes for questions.
For more information, visit
http://www.cancer.gov/cam/news/monthly-lecture-series.html
Evaluation of Resveratrol and Curcumin as Therapeutics Against High Risk Leukemia
-
- Recombinant DNA Advisory Committee (RAC) September 2009
-
- - National Institutes of Health (U.S.). Recombinant DNA Advisory Committee. (2010/11/18)
- - Category : Recombinant DNA Advisory Committee
- The RAC is a technical committee whose goal is to consider the current state of knowledge and technology regarding recombinant DNA. This includes review of human gene transfer trials, and an assessment of the ability of DNA recombinants to survive in nature and the potential for transfer of genetic material to other organisms. It also considers hypothetical hazards and methods for monitoring and minimizing risks. Approximately one-third of the 15 members do not have scientific expertise but represent public interests and attitudes. This balance is intended to provide a forum for open public debate of social and scientific issues attendant to recombinant DNA research. The RAC has been overwhelmingly successful in achieving this goal.
For more information, visit the
Recombinant DNA Advisory Committee (RAC) Conference Web Site
Recombinant DNA Advisory Committee (RAC) September 2009
-
- Sex and Gender Research: The Interaction of Depression with Other Diseases
-
- - Goldstein, Jill M. (2010/11/18)
- - Category : Womens Health
- ORWH Women？？？s Health Seminar Series
The National Institutes of Health (NIH) Office of Research on Women？？？s Health (ORWH) Women？？？s Health Seminar Series will present an afternoon of discussion with national experts on the interaction of depression with other diseases. Vivian W. Pinn, M.D., Associate Director for Research on Women？？？s Health and Director, Office of Research on Women？？？s Health at NIH will present the opening remarks.
Fetal Antecedents to Depression
Jill M. Goldstein, Ph.D.
Brigham and Women？？？s Hospital, Harvard Medical School
Depression and Bone Health
Giovanni Cizza, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
Depression and Cancer
Mary Jane Massie, M.D.
Memorial Sloan-Kettering Cancer Center
Depression and Heart Disease
Viola Vaccarino, M.D., Ph.D.
Emory University School of Medicine
For more information, visit
http://orwh.od.nih.gov
Sex and Gender Research: The Interaction of Depression with Other Diseases
-
- Update on Infertility Research and Implications for Clinical Practice
-
- - Segars, James.
National Institutes of Health (U.S.). Womens Health Special Interest Group. (2010/11/18) - - Category : Womens Health
- - Segars, James.
- Womens Health Special Interest Group (WHSIG)
Intramural Program on Research on Womens Health
Sponsored by the NIH Office of Intramural Research
and the NIH Office of Research on Womens Health.
Come join your fellow NIH colleagues in a scientific exchange on issues related to the biology and pathology of sex and gender differences and effects on womens health.
For more information, visit
http://orwh.od.nih.gov
Update on Infertility Research and Implications for Clinical Practice